<code id='BE87443830'></code><style id='BE87443830'></style>
    • <acronym id='BE87443830'></acronym>
      <center id='BE87443830'><center id='BE87443830'><tfoot id='BE87443830'></tfoot></center><abbr id='BE87443830'><dir id='BE87443830'><tfoot id='BE87443830'></tfoot><noframes id='BE87443830'>

    • <optgroup id='BE87443830'><strike id='BE87443830'><sup id='BE87443830'></sup></strike><code id='BE87443830'></code></optgroup>
        1. <b id='BE87443830'><label id='BE87443830'><select id='BE87443830'><dt id='BE87443830'><span id='BE87443830'></span></dt></select></label></b><u id='BE87443830'></u>
          <i id='BE87443830'><strike id='BE87443830'><tt id='BE87443830'><pre id='BE87443830'></pre></tt></strike></i>

          leisure time

          leisure time

          author:explore    Page View:68
          Trump Campaign Event In Nevada
          Ethan Miller/Getty Images

          WASHINGTON — Former President Trump is back to campaigning for tying Medicare drug prices to lower prices abroad.

          In Trump fashion, he claimed in a video announcement this month that he is the “only president in modern times” to take on the drug industry — and dinged President Biden directly.

          advertisement

          “Biden canceled my tough-on-pharma policies the moment he had a chance,” Trump said.

          Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

          GET STARTED Log In

          explore

          Medicare details structure of new drug price negotiation program
          Medicare details structure of new drug price negotiation program

          MedicareonFridayreleasednewdetailsabouthowitsnewdrugpricenegotiationprogramwillwork,justtwomonthsbef

          read more
          U.K. agency declines to back Eli Lilly’s Mounjaro for type 2 diabetes
          U.K. agency declines to back Eli Lilly’s Mounjaro for type 2 diabetes

          DarronCummings/APLONDON—AU.K.governmentagencyonTuesdaysaidthatitwon’trecommendEliLilly’sMounjaro—par

          read more
          Psychedelics group wrestles with new pharma identity
          Psychedelics group wrestles with new pharma identity

          OliviaGoldhill/STATDENVER—Hecouldhavebeenarockstar,areligiousicon,thewayecstaticapplausefromthousand

          read more

          Senate panel passes drug pricing bills, but drops one PBM reform

          CommitteeRankingRepublicanBillCassidy(La.)andChairmanBernieSanders(I-Vt.)ChipSomodevilla/GettyImages